SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-509290"
 

Search: onr:"swepub:oai:DiVA.org:uu-509290" > Defining Strategies...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Capodanno, DavideUniv Catania, Azienda Osped Univ Policlin G Rodolico San Marco, Catania, Italy. (author)

Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease : A Consensus Document from the Academic Research Consortium

  • Article/chapterEnglish2023

Publisher, publication year, extent ...

  • Ovid Technologies (Wolters Kluwer Health),2023
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-509290
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-509290URI
  • https://doi.org/10.1161/CIRCULATIONAHA.123.064473DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Antiplatelet therapy is the mainstay of pharmacologic treatment to prevent thrombotic or ischemic events in patients with coronary artery disease treated with percutaneous coronary intervention and those treated medically for an acute coronary syndrome. The use of antiplatelet therapy comes at the expense of an increased risk of bleeding complications. Defining the optimal intensity of platelet inhibition according to the clinical presentation of atherosclerotic cardiovascular disease and individual patient factors is a clinical challenge. Modulation of antiplatelet therapy is a medical action that is frequently performed to balance the risk of thrombotic or ischemic events and the risk of bleeding. This aim may be achieved by reducing (ie, de-escalation) or increasing (ie, escalation) the intensity of platelet inhibition by changing the type, dose, or number of antiplatelet drugs. Because de-escalation or escalation can be achieved in different ways, with a number of emerging approaches, confusion arises with terminologies that are often used interchangeably. To address this issue, this Academic Research Consortium collaboration provides an overview and definitions of different strategies of antiplatelet therapy modulation for patients with coronary artery disease, including but not limited to those undergoing percutaneous coronary intervention, and consensus statements on standardized definitions.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Mehran, RoxanaIcahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY USA.;Pharmaceut & Med Devices Agcy, Tokyo, Japan. (author)
  • Krucoff, Mitchell W.Duke Univ, Med Ctr, Durham, NC USA. (author)
  • Baber, UsmanUniv Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA. (author)
  • Bhatt, Deepak L.Icahn Sch Med Mt Sinai, Mt Sinai Heart, New York, NY USA. (author)
  • Capranzano, PieraUniv Catania, Azienda Osped Univ Policlin G Rodolico San Marco, Catania, Italy. (author)
  • Collet, Jean-PhilippeSorbonne Univ, Hop Pitie Salpetriere, AP HP, ACTION Study Grp,Inst Cardiol, Paris, France. (author)
  • Cuisset, ThomasUniv Hosp La Timone, Dept Cardiol, Intervent Cardiol Unit, Marseille, France.;Univ Hosp La Timone, Dept Cardiol, Cathlab, Marseille, France. (author)
  • De Luca, GiuseppeUniv Messina, Div Cardiol, Azienda Osped Univ Policlin G Martino, Messina, Italy.;IRCCS Hosp Galeazzi St Ambrogio, Div Cardiol, Milan, Italy. (author)
  • De Luca, LeonardoAzienda Osped San Camillo Forlanini, Dept Cardiothorac & Vasc Med & Surg, Div Cardiol, Rome, Italy.;UniCamillus St Camillus Int Univ Hlth Sci, Rome, Italy. (author)
  • Farb, AndrewUS FDA, Silver Spring, MD USA. (author)
  • Franchi, FrancescoUniv Florida, Div Cardiol, Coll Med, Jacksonville, FL USA. (author)
  • Gibson, C. MichaelBaim Inst Clin Res, Boston, MA USA. (author)
  • Hahn, Joo-YongSungkyunkwan Univ, Heart Vasc Stroke Inst, Samsung Med Ctr, Sch Med, Seoul, South Korea. (author)
  • Hong, Myeong-KiYonsei Univ, Severance Hosp, Div Cardiol, Coll Med, Seoul, South Korea. (author)
  • James, Stefan,1964-Uppsala universitet,Institutionen för medicinska vetenskaper,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)stjam367 (author)
  • Kastrati, AdnanTech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany.;Deutsch Zentrum Herz Kreislauf Forsch DZHK, Munich, Germany.;German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany. (author)
  • Kimura, TakeshiHirakata Kohsai Hosp, Dept Cardiol, Osaka, Japan. (author)
  • Lemos, Pedro A.Hosp Israelita Albert Einstein, Sao Paulo, Brazil. (author)
  • Lopes, Renato D.Duke Univ, Med Ctr, Durham, NC USA. (author)
  • Magee, AdrianUS FDA, Silver Spring, MD USA. (author)
  • Matsumura, Ryosuke (author)
  • Mochizuki, ShuichiPharmaceut & Med Devices Agcy, Tokyo, Japan. (author)
  • O'Donoghue, Michelle L.Brigham & Womens Hosp, Cardiovasc Div, TIMI Study Grp, Boston, MA USA. (author)
  • Pereira, Naveen L.Mayo Clin, Dept Cardiovasc Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA. (author)
  • Rao, Sunil V.NYU Langone Hlth Syst, New York, NY USA. (author)
  • Rollini, FabianaUniv Florida, Div Cardiol, Coll Med, Jacksonville, FL USA. (author)
  • Shirai, YukoPharmaceut & Med Devices Agcy, Tokyo, Japan. (author)
  • Sibbing, DirkDeutsch Zentrum Herz Kreislauf Forsch DZHK, Munich, Germany.;German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany.;Ludwig Maximilians Univ Munchen, Munich, Germany.;Privatklin Lauterbacher Muhle Ostsee, Seeshaupt, Germany. (author)
  • Smits, Peter C.Maasstad Hosp, Dept Cardiol, Rotterdam, Netherlands. (author)
  • Steg, P. GabrielUniv Paris Cite, AP HP, Paris, France.;INSERM U1148 LVTS, Paris, France.;Inst Univ France, Paris, France. (author)
  • Storey, Robert F.Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield, England. (author)
  • ten Berg, JurrienMaastricht Univ Med Ctr, Cardiovasc Res Inst Maastricht CARIM, Sch Cardiovasc Dis, Maastricht, Netherlands.;St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands.;Univ Med Ctr Maastricht, Dept Cardiol, Maastricht, Netherlands. (author)
  • Valgimigli, MarcoUniv Svizzera Italiana USI, Cardioctr Inst, Osped Cantonale, Lugano, Switzerland.;Univ Bern, Bern, Switzerland. (author)
  • Vranckx, PascalJessa Ziekenhuis, Dept Cardiol & Crit Care Med, Hasselt, Belgium.;Univ Hasselt, Fac Med & Life Sci, Hasselt, Belgium. (author)
  • Watanabe, HirotoshiHirakata Kohsai Hosp, Dept Cardiol, Osaka, Japan. (author)
  • Windecker, StephanBern Univ Hosp, Dept Cardiol, Inselspital, Bern, Switzerland. (author)
  • Serruys, Patrick W.Univ Galway, Dept Cardiol, Galway, Ireland. (author)
  • Yeh, Robert W.Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA USA. (author)
  • Morice, Marie-ClaudeICPS, Paris, France.;CERC, Paris, France. (author)
  • Angiolillo, Dominick J.Univ Florida, Div Cardiol, Coll Med, Jacksonville, FL USA. (author)
  • Univ Catania, Azienda Osped Univ Policlin G Rodolico San Marco, Catania, Italy.Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY USA.;Pharmaceut & Med Devices Agcy, Tokyo, Japan. (creator_code:org_t)

Related titles

  • In:Circulation: Ovid Technologies (Wolters Kluwer Health)147:25, s. 1933-19440009-73221524-4539

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view